...Operator Thanks for standing by. Welcome to today's Imogene investor update and Q&A webinar. Following the recent announcements regarding ASacL being accepted for oral presentation at the renowned ASH meeting, as well as new data showing ASacL's efficacy in CART naive niche indications. Joining us from Imogene today, we have the CEO and Managing Director, Leslie Chong, and the Chief Medical Officer, Doctor John Bon. In terms of the format, there'll be an initial presentation that will last for approximately 15 or 20 minutes. Following this, we'll take questions, so if you have a question you'd like to submit, please type it in using the Q&A panel within Zoom, and we'll get to those later on. Leslie, I'll hand it over to you. Leslie Chong ...